메뉴 건너뛰기




Volumn 111, Issue 2, 2014, Pages 173-180

Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy;Mineralokortikoidrezeptorantagonisten als Therapieoption bei akuter und chronischer Chorioretinopathia centralis serosa

Author keywords

Choroid; Glucocorticoid; Pathomechanism; Pharmaceutical block; Therapy

Indexed keywords

MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE;

EID: 84893637365     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-013-3001-0     Document Type: Article
Times cited : (21)

References (36)
  • 1
    • 80051840200 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for the treatment of central serous chorioretinopathy
    • Alomran MS (2010) Intravitreal bevacizumab for the treatment of central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2:1-3
    • (2010) Ophthalmic Surg Lasers Imaging , vol.2 , pp. 1-3
    • Alomran, M.S.1
  • 2
    • 76749090086 scopus 로고    scopus 로고
    • Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: A prospective, controlled clinical study
    • Artunay O, Yuzbasioglu E, Rasier R et al (2010) Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study. Curr Eye Res 35:91-98
    • (2010) Curr Eye Res , vol.35 , pp. 91-98
    • Artunay, O.1    Yuzbasioglu, E.2    Rasier, R.3
  • 3
    • 77952428325 scopus 로고    scopus 로고
    • Central serous chorioretinopathy (CSC)
    • Baraki H, Feltgen N, Roider J et al (2010) Central serous chorioretinopathy (CSC). Ophthalmologe 107:479-492
    • (2010) Ophthalmologe , vol.107 , pp. 479-492
    • Baraki, H.1    Feltgen, N.2    Roider, J.3
  • 5
    • 84887086979 scopus 로고    scopus 로고
    • Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy
    • Bousquet E, Beydoun T, Zhao M et al (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy. A pilot study. Retina 33(10):2096-2102
    • (2013) A Pilot Study. Retina , vol.33 , Issue.10 , pp. 2096-2102
    • Bousquet, E.1    Beydoun, T.2    Zhao, M.3
  • 6
  • 7
    • 33750370418 scopus 로고    scopus 로고
    • Selektive Retinatherapie: Methodik, Technik und Online-Dosimetrie
    • Brinkmann R, Schule G, Neumann J et al (2006) Selektive Retinatherapie: Methodik, Technik und Online-Dosimetrie. Ophthalmologe 103:839-849
    • (2006) Ophthalmologe , vol.103 , pp. 839-849
    • Brinkmann, R.1    Schule, G.2    Neumann, J.3
  • 8
    • 52949152772 scopus 로고    scopus 로고
    • Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: One-year results of a randomized controlled trial
    • Chan WM et al (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756-1765
    • (2008) Ophthalmology , vol.115 , pp. 1756-1765
    • Chan, W.M.1
  • 9
    • 0346887106 scopus 로고    scopus 로고
    • Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level
    • Chan WM et al (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453-1458
    • (2003) Br J Ophthalmol , vol.87 , pp. 1453-1458
    • Chan, W.M.1
  • 10
    • 56549098429 scopus 로고    scopus 로고
    • Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage
    • Chen SN et al (2008) Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 115:2229-2234
    • (2008) Ophthalmology , vol.115 , pp. 2229-2234
    • Chen, S.N.1
  • 11
    • 33750355559 scopus 로고    scopus 로고
    • Selective retina therapy in patients with central serous chorioretinopathy
    • Elsner H et al (2006) Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 244:1638-1645
    • (2006) Graefes Arch Clin Exp Ophthalmol , vol.244 , pp. 1638-1645
    • Elsner, H.1
  • 12
    • 79955068635 scopus 로고    scopus 로고
    • Finasteride for chronic central serous chorioretinopathy
    • Forooghian F, Meleth AD, Cukras C et al (2011) Finasteride for chronic central serous chorioretinopathy. Retina 31(4):766-771
    • (2011) Retina , vol.31 , Issue.4 , pp. 766-771
    • Forooghian, F.1    Meleth, A.D.2    Cukras, C.3
  • 13
    • 17644416763 scopus 로고    scopus 로고
    • Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy
    • Framme C et al (2005) Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy. Acta Ophthalmol Scand 83:161-167
    • (2005) Acta Ophthalmol Scand , vol.83 , pp. 161-167
    • Framme, C.1
  • 14
    • 0000760891 scopus 로고
    • Über die zentrale rezidivierende Retinitis
    • Graefe A (1866) Über die zentrale rezidivierende Retinitis. Graefes Arch Ophthalmol 12:211-215
    • (1866) Graefes Arch Ophthalmol , vol.12 , pp. 211-215
    • Graefe, A.1
  • 15
    • 77952239818 scopus 로고    scopus 로고
    • Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy
    • Gupta P et al (2010) Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol 30:175-181
    • (2010) Int Ophthalmol , vol.30 , pp. 175-181
    • Gupta, P.1
  • 16
    • 73349109845 scopus 로고    scopus 로고
    • Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy
    • Imamura Y, Fujuwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469-1473
    • (2009) Retina , vol.29 , pp. 1469-1473
    • Imamura, Y.1    Fujuwara, T.2    Margolis, R.3    Spaide, R.F.4
  • 17
    • 0038694739 scopus 로고    scopus 로고
    • Features of abnormal choroidal circulation in central serous chorioretinopathy
    • Kitaya N, Nagaoka T, Hikichi T et al (2003) Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87:709-712
    • (2003) Br J Ophthalmol , vol.87 , pp. 709-712
    • Kitaya, N.1    Nagaoka, T.2    Hikichi, T.3
  • 18
    • 37349087448 scopus 로고    scopus 로고
    • The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002
    • Kitzmann AS, Pulido JS, Diehl NN et al (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 115:169-173
    • (2008) Ophthalmology , vol.115 , pp. 169-173
    • Kitzmann, A.S.1    Pulido, J.S.2    Diehl, N.N.3
  • 19
    • 33750319947 scopus 로고    scopus 로고
    • Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium
    • Klatt C et al (2006) Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium. Ophthalmologe 103:850-855
    • (2006) Ophthalmologe , vol.103 , pp. 850-855
    • Klatt, C.1
  • 20
    • 84856592303 scopus 로고    scopus 로고
    • Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy
    • Koss MJ, Beger I, Koch FH (2012) Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond) 26(2):307-314
    • (2012) Eye (Lond) , vol.26 , Issue.2 , pp. 307-314
    • Koss, M.J.1    Beger, I.2    Koch, F.H.3
  • 21
    • 81255208676 scopus 로고    scopus 로고
    • Therapy options for chronic central serous chorioretinopathy.Photodynamic therapy combined with bevacizumab-a case series
    • Maier M, Valet V, Feucht N, Lohmann CP (2011) Therapy options for chronic central serous chorioretinopathy. Photodynamic therapy combined with bevacizumab - a case series. Ophthalmologe 108(11):1027-1031
    • (2011) Ophthalmologe , vol.108 , Issue.11 , pp. 1027-1031
    • Maier, M.1    Valet, V.2    Feucht, N.3    Lohmann, C.P.4
  • 22
    • 84893638374 scopus 로고    scopus 로고
    • Spironolacton als Therapieoption bei akuter und chronischer Chorioretinopathia centralis serosa (CCS): Eine Fallserie
    • Maier M, Strobl P, Feucht N et al (2013) Spironolacton als Therapieoption bei akuter und chronischer Chorioretinopathia centralis serosa (CCS): Eine Fallserie, Abstract DOG 2013
    • (2013) Abstract DOG , pp. 2013
    • Maier, M.1    Strobl, P.2    Feucht, N.3
  • 23
    • 77956344003 scopus 로고    scopus 로고
    • Subfoveal choroidal thickness after treatment of central serous chorioretinopathy
    • Maruko I, Iida T, Sugano Y et al (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792-1799
    • (2010) Ophthalmology , vol.117 , pp. 1792-1799
    • Maruko, I.1    Iida, T.2    Sugano, Y.3
  • 24
    • 34748827379 scopus 로고    scopus 로고
    • Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy
    • Meyerle CB, Freund KB, Bhatnagar P et al (2007) Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina 27:943-946
    • (2007) Retina , vol.27 , pp. 943-946
    • Meyerle, C.B.1    Freund, K.B.2    Bhatnagar, P.3
  • 25
    • 0036711687 scopus 로고    scopus 로고
    • Acetazolamide for central serous retinopathy
    • Pikkel J, Beiran I, Ophir A et al (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109:1723-1725
    • (2002) Ophthalmology , vol.109 , pp. 1723-1725
    • Pikkel, J.1    Beiran, I.2    Ophir, A.3
  • 26
    • 70549098654 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy
    • Schaal KB, Hoeh AE, Scheuerle A et al (2009) Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 19:613-617
    • (2009) Eur J Ophthalmol , vol.19 , pp. 613-617
    • Schaal, K.B.1    Hoeh, A.E.2    Scheuerle, A.3
  • 27
    • 1442310971 scopus 로고    scopus 로고
    • Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy
    • Spahn C, Wiek J, Burger T (2004) Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy. Psychother Psychosom Med Psychol 54:52-57
    • (2004) Psychother Psychosom Med Psychol , vol.54 , pp. 52-57
    • Spahn, C.1    Wiek, J.2    Burger, T.3
  • 28
    • 0038694741 scopus 로고    scopus 로고
    • Psychosomatic aspects in patients with central serous chorioretinopathy
    • Spahn C, Wiek J, Burger T et al (2003) Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 87:704-708
    • (2003) Br J Ophthalmol , vol.87 , pp. 704-708
    • Spahn, C.1    Wiek, J.2    Burger, T.3
  • 29
    • 0030442879 scopus 로고    scopus 로고
    • Central serous chorioretinopathy in younger and older adults
    • Spaide RF, Campeas L, Haas A et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070-2080
    • (1996) Ophthalmology , vol.103 , pp. 2070-2080
    • Spaide, R.F.1    Campeas, L.2    Haas, A.3
  • 30
    • 8944254250 scopus 로고    scopus 로고
    • Indocyanine green videoangiography of older patients with central serous chorioretinopathy
    • Spaide RF, Hall L, Haas A et al (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203-213
    • (1996) Retina , vol.16 , pp. 203-213
    • Spaide, R.F.1    Hall, L.2    Haas, A.3
  • 32
    • 84865818650 scopus 로고    scopus 로고
    • Spectral domain OCT in central serous chorioretinopathy: Description of retinal changes (Spectralis OCT bei Chorioretinopathia centralis serosa)
    • Valet V, Lohmann CP, Maier M (2012) Spectral domain OCT in central serous chorioretinopathy: description of retinal changes (Spectralis OCT bei Chorioretinopathia centralis serosa). Ophthalmologe 109(9):879-887
    • (2012) Ophthalmologe , vol.109 , Issue.9 , pp. 879-887
    • Valet, V.1    Lohmann, C.P.2    Maier, M.3
  • 34
    • 0037742644 scopus 로고    scopus 로고
    • Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: A pilot study
    • Yannuzzi LA, Slakter JS, Gross NE et al (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288-298
    • (2003) Retina , vol.23 , pp. 288-298
    • Yannuzzi, L.A.1    Slakter, J.S.2    Gross, N.E.3
  • 35
    • 77049089780 scopus 로고    scopus 로고
    • Central serous chorioretinopathy: A personal perspective
    • Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361-363
    • (2010) Am J Ophthalmol , vol.149 , pp. 361-363
    • Yannuzzi, L.A.1
  • 36
    • 84863548606 scopus 로고    scopus 로고
    • Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
    • Zhao M, Célérier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672-2679
    • (2012) J Clin Invest , vol.122 , Issue.7 , pp. 2672-2679
    • Zhao, M.1    Célérier, I.2    Bousquet, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.